Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, Cancer, Hypoxia, and Metabolism, and Radiopharmaceutical Chemistry and Applications.
1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
18F-labeled tracers targeting fibroblast activation protein
Ligand engineering for theranostic applications
FAPI-74 PET/CT Using Either<sup>18</sup>F-AlF or Cold-Kit<sup>68</sup>Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
The Latest Developments in Imaging of Fibroblast Activation Protein
Design and Development of <sup>99m</sup>Tc-Labeled FAPI Tracers for SPECT Imaging and <sup>188</sup>Re Therapy
Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery
Ga-68-FAPI PET/CT: Ein Überblick zum Tracer-Uptake bei 28 unterschiedlichen Tumorentitäten
Fluor-18-markierte FAPI-Tracer für die PET-Bildgebung
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
Targeting of activated fibroblasts for imaging and therapy
IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT
PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide
Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Comparison of the RGD Motif–Containing α<sub>v</sub>β<sub>6</sub>Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC
Identification of a Novel ITGαvβ6-Binding Peptide Using Protein Separation and Phage Display
Identification of Ligands and Translation to Clinical Applications
Screening of a Novel Peptide Targeting the Proteoglycan-Like Region of Human Carbonic Anhydrase IX
Peptide Arrays for Development of PDGFRβ Affine Molecules
PEGylation enables the specific tumor accumulation of a peptide identified by phage display
Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma
Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta
Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX